5 Results for "

human type B hepatitis

" in MedChemExpress (MCE) Product Catalog:
Products (5)

5 Results for "human type B hepatitis" in MCE Product Catalog:

1
1 Cited Publications
Cat. No.: HY-P702076
Purity:  ≥ 80%, as determined by reducing SDS-PAGE.
Synonyms: RBCK1; hepatitis B Virus X-Associated Protein 4; Prev. C20orf18; RING Finger Protein 54; UBCE7IP3; HOIL-1; RNF54; XAP3; XAP4; CDNA FLJ60704, Highly Similar To RanBP-type And C3HC4-type Zincfinger-Containing Protein 1; RanBP-type And C3HC4-type Zinc Finger
Species:  
Source:  
loading...
    loading...
Cat. No.: HY-P99693
CAS No.: 2055006-79-4
Synonyms: GC1102

Target:  

HBV

Research Areas:  

Infection

Lenvervimab (GC1102) is a IgG1-type recombinant human hepatitis B Immunoglobulin. Lenvervimab can be used for research of hepatitis B virus infection .
loading...
    loading...
Cat. No.: HY-14844
CAS No.: 92562-88-4
Synonyms: MIV-210
Target:  

HBV

Research Areas:  

Infection

Lagociclovir (FLG) is a nucleoside analogue that inhibits wild-type hepatitis B virus (HBV) replication in a human hepatoma cell line permanently expressing HBV .
loading...
    loading...
Cat. No.: HY-N17557
CAS No.: 343326-65-8
Synonyms: Schizarin D
Schizanrin D (Schizarin D) is a C18 Dibenzocyclooctadiene lignin. Schizanrin D can be derived from dried stems of Kadsura matsudai. Schizanrin D inhibits HBeAg production. Schizanrin D is inactive in vitro against HIV replication .
loading...
    loading...
Cat. No.: HY-L101
2,960 compounds

Liver cancer is one of the leading malignancies which occupies the second position in cancer deaths worldwide, becoming serious threat to human health. Hepatocellular carcinoma (HCC), also known as hepatoma is the most common type accounting for approximately 90% of all liver cancers.

Current evidence indicates that during hepatocarcinogenesis, two main pathogenic mechanisms prevail: (1) cirrhosis associated with hepatic regeneration after tissue damage caused by hepatitis infection, toxins or metabolic influences, and (2) mutations occurring in single or multiple oncogenes or tumor suppressor genes. Both mechanisms have been linked with alterations in several important cellular signaling pathways. These include the RAF/MEK/ERK pathway, PI3K/AKT/mTOR pathway, WNT/b-catenin pathway, insulin-like growth factor pathway, c-MET/HGFR pathway , etc.

MCE offers a unique collection of 2,960 compounds with identified and potential anti-liver cancer activity. MCE anti-liver cancer compound library is a useful tool for anti-liver cancer drugs screening and other related research.